MGAT5
From Wikipedia, the free encyclopedia
Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | MGAT5; GNT-V | |||||||||||||
External IDs | OMIM: 601774 MGI: 894701 HomoloGene: 1808 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 4249 | 107895 | ||||||||||||
Ensembl | ENSG00000152127 | ENSMUSG00000036155 | ||||||||||||
Uniprot | Q09328 | Q059T5 | ||||||||||||
Refseq | NM_002410 (mRNA) NP_002401 (protein) |
XM_912670 (mRNA) XP_917763 (protein) |
||||||||||||
Location | Chr 2: 134.73 - 134.92 Mb | Chr 1: 129.03 - 129.31 Mb | ||||||||||||
Pubmed search | [1] | [2] |
Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, also known as MGAT5, is a human gene.[1]
This gene encodes mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, a glycosyltransferase involved in the synthesis of protein-bound and lipid-bound oligosaccharides. Alterations of the oligosaccharides on cell surface glycoproteins cause significant changes in the adhesive or migratory behavior of a cell. Increase in the encoded protein's activity may correlate with the progression of invasive malignancies.[1]
[edit] References
[edit] Further reading
- Dennis JW, Granovsky M, Warren CE (2000). "Glycoprotein glycosylation and cancer progression.". Biochim. Biophys. Acta 1473 (1): 21-34. PMID 10580127.
- Saito H, Nishikawa A, Gu J, et al. (1994). "cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V+.". Biochem. Biophys. Res. Commun. 198 (1): 318-27. PMID 8292036.
- Buckhaults P, Chen L, Fregien N, Pierce M (1997). "Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene.". J. Biol. Chem. 272 (31): 19575-81. PMID 9235963.
- Park C, Jin UH, Lee YC, et al. (1999). "Characterization of UDP-N-acetylglucosamine:alpha-6-d-mannoside beta-1,6-N-acetylglucosaminyltransferase V from a human hepatoma cell line Hep3B.". Arch. Biochem. Biophys. 367 (2): 281-8. doi: . PMID 10395745.
- Granovsky M, Fata J, Pawling J, et al. (2000). "Suppression of tumor growth and metastasis in Mgat5-deficient mice.". Nat. Med. 6 (3): 306-12. doi: . PMID 10700233.
- Ihara S, Miyoshi E, Ko JH, et al. (2002). "Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching.". J. Biol. Chem. 277 (19): 16960-7. doi: . PMID 11864986.
- Saito T, Miyoshi E, Sasai K, et al. (2002). "A secreted type of beta 1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation: a novel function of GnT-V distinct from the original glycosyltransferase activity.". J. Biol. Chem. 277 (19): 17002-8. doi: . PMID 11872751.
- Dosaka-Akita H, Miyoshi E, Suzuki O, et al. (2004). "Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers.". Clin. Cancer Res. 10 (5): 1773-9. PMID 15014031.
- Guo P, Zhang Y, Shen ZH, et al. (2004). "Effect of N-acetylglucosaminyltransferase V on the expressions of other glycosyltransferases.". FEBS Lett. 562 (1-3): 93-8. doi: . PMID 15044007.
- Kim CH (2005). "Increased expression of N-acetylglucosaminyltransferase-V in human hepatoma cells by retinoic acid and 1alpha,25-dihydroxyvitamin D3.". Int. J. Biochem. Cell Biol. 36 (11): 2307-19. doi: . PMID 15313475.
- Tomiie M, Isaka S, Miyoshi E, et al. (2005). "Elevated expression of N-acetylglucosaminyltransferase V in first trimester human placenta.". Biochem. Biophys. Res. Commun. 330 (3): 999-1004. doi: . PMID 15809094.
- Fang H, Huang W, Xu YY, et al. (2006). "Blocking of N-acetylglucosaminyltransferase V induces cellular endoplasmic reticulum stress in human hepatocarcinoma 7,721 cells.". Cell Res. 16 (1): 82-92. doi: . PMID 16467879.
- Ishimura H, Takahashi T, Nakagawa H, et al. (2006). "N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer.". Clin. Cancer Res. 12 (8): 2506-11. doi: . PMID 16638859.
- Wang L, Liang Y, Li Z, et al. (2007). "Increase in beta1-6 GlcNAc branching caused by N-acetylglucosaminyltransferase V directs integrin beta1 stability in human hepatocellular carcinoma cell line SMMC-7721.". J. Cell. Biochem. 100 (1): 230-41. doi: . PMID 16924681.
- Li J, Wang XM, Wang Q, et al. (2007). "Down-regulation of N-acetylglucosaminyltransferase-V induces ER stress by changing glycosylation and function of GLUT1.". Arch. Biochem. Biophys. 463 (1): 102-9. doi: . PMID 17451637.
- Kudo T, Nakagawa H, Takahashi M, et al. (2007). "N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma.". Mol. Cancer 6: 32. doi: . PMID 17488527.